Filing Details
- Accession Number:
- 0000950103-24-012152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-13 17:09:47
- Reporting Period:
- 2024-08-09
- Accepted Time:
- 2024-08-13 17:09:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356090 | Precigen Inc. | PGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1617812 | Thomas Jeffrey Perez | 20358 Seneca Meadows Parkway Germantown MD 20876 | Svp, Ip Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-09 | 58,823 | $0.85 | 743,097 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased shares of Precigen common stock in connection with the issuer's follow-on offering, which closed on August 9, 2024. The purchase price is the offering price.
Billionaire Hedge Funds
